Items where Author is "Brogi, S."

Article

(2025) Combining Subtractive Genomics with Computer-Aided Drug Discovery Techniques to Effectively Target S. sputigena in Periodontitis. Computation. p. 24.

(2024) Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization. Journal of Medicinal Chemistry. pp. 1758-1782. ISSN 0022-2623

(2024) Discovery of novel direct small-molecule inhibitors targeting HIF-2alpha using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations. Molecular diversity. pp. 1203-1224. ISSN 1573-501X (Electronic) 1381-1991 (Linking)

(2024) Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach. Foods. p. 44.

(2024) Natural products as non-covalent and covalent modulators of the KEAP1/ NRF2 pathway exerting antioxidant effects. European Journal of Medicinal Chemistry. p. 35. ISSN 0223-5234

(2024) Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy. Journal of Medicinal Chemistry. pp. 14946-14973. ISSN 0022-2623

(2024) A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients. Biomedicine & Pharmacotherapy. p. 13. ISSN 0753-3322

(2023) Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes. International Journal of Molecular Sciences. p. 23. ISSN 1661-6596

(2023) In Silico Identification of Natural Products and World-Approved Drugs Targeting the KEAP1/NRF2 Pathway Endowed with Potential Antioxidant Profile. Computation. p. 27.

(2023) Novel Antiviral Agents: Synthesis, Molecular Modelling Studies and Biological Investigation. Viruses. ISSN 1999-4915 (Electronic) 1999-4915 (Linking)

(2023) Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel SARS-CoV-2 NSP3 Mac1 Domain Inhibitors. Viruses-Basel. p. 21.

(2021) Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening. Comput Biol Med. ISSN 0010-4825 1879-0534 J9 - COMPUT BIOL MED

(2020) Amyloid beta fibril disruption by oleuropein aglycone: long-time molecular dynamics simulation to gain insight into the mechanism of action of this polyphenol from extra virgin olive oil. Food & Function. pp. 8122-8132. ISSN 2042-6496

(2020) Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors. Molecules.

(2019) Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach. Frontiers in Chemistry. p. 20. ISSN 2296-2646

(2019) Synthesis, Molecular odelling and Biological Studies of 3-hydroxypyrane-4-one and 3-hydroxy-nyridine-4-one Derivatives as HIV-1 Integrase Inhibitors. Medicinal Chemistry. pp. 755-770. ISSN 1573-4064

(2019) An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction. Computational Biology and Chemistry. p. 16. ISSN 1476-9271

(2018) Synthesis, Molecular Modelling and Biological Studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors. Med Chem. ISSN 1875-6638 (Electronic) 1573-4064 (Linking)